Login to Your Account

Financings Roundup

ChemoCentryx Prices $45M IPO; Platforms, Partners Prevail

By Trista Morrison
Staff Writer

Thursday, February 9, 2012
ChemoCentryx Inc. raised $45 million in its initial public offering (IPO), following Cempra Inc. and Verastem Inc. out an IPO window that, over the last few years, has proved selective at best.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription